Life ScienceCompany
Trigemina - Non-Addictive Migraine and Pain Treatment Programs Ownership
Who owns Trigemina - Non-Addictive Migraine and Pain Treatment Programs?
Trigemina - Non-Addictive Migraine and Pain Treatment Programs is owned by Tonix Pharmaceuticals Holding. It was acquired on June 11, 2020.
Trigemina - Non-Addictive Migraine and Pain Treatment Programs Business Overview
Where is Trigemina - Non-Addictive Migraine and Pain Treatment Programs headquartered?
Trigemina - Non-Addictive Migraine and Pain Treatment Programs is headquartered in California.
What sector is Trigemina - Non-Addictive Migraine and Pain Treatment Programs in?
Trigemina - Non-Addictive Migraine and Pain Treatment Programs is a life science company.
Life Science M&A Summary in 2020
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.
Join Mergr to view all 285 acquisitions of life science companies in 2020, including 23 acquisitions by private equity firms, and 262 by strategics.